Transgene Biotek

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE773D01018
  • NSEID:
  • BSEID: 526139
INR
2.85
-0.06 (-2.06%)
BSENSE

Aug 10, 10:00 AM

BSE+NSE Vol: 2.54 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 408336,
    "name": "Transgene Biotek",
    "stock_name": "Transgene Biotek",
    "full_name": "Transgene Biotek Ltd",
    "name_url": "stocks-analysis/transgene-biotek",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.85",
    "chg": -0.06,
    "chgp": "-2.06%",
    "dir": -1,
    "prev_price": "2.91",
    "mcapval": "22.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526139,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE773D01018",
    "curr_date": "Aug 10, 10:00 AM",
    "curr_time": "10:03 AM",
    "last_traded_at": "Aug 10, 10:00 AM IST",
    "bse_nse_vol": "2.54 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transgene-biotek-408336-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Transgene Biotek Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-transgene-biotek-ltd-4119863",
        "imagepath": "",
        "date": "2026-07-24 23:16:57",
        "description": "The next results date for Transgene Biotek Ltd is scheduled for 07 August 2026...."
      }
    ],
    "total": 80,
    "sid": "408336",
    "stock_news_url": "https://www.marketsmojo.com/news/transgene-biotek-408336"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07 2026.",
      "datetime": "07-Aug-2026",
      "details": "Sub: Outcome of the Meeting of the Board of Directors held on August 07 2026.",
      "source": "BSE"
    },
    {
      "caption": "1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.",
      "datetime": "07-Aug-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of The Board Meeting.",
      "datetime": "23-Jul-2026",
      "details": "Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby infom you that a meeting of the Board of Directors of Transgene Biotek Limited is scheduled to be held on Friday August 07 2026 inter alia to consider and approve the following matters: 1. To consider and approve the n-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30 2026. 2. To consider and approve the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30h June 2026. 3. To consider and approve seeking an extension of time for holding the Annual General Meeting (AGM) of the Company for the Financial Year 2025-26. 4. To consider and approve the appointment of the internal auditor of the Company for financial year 2026-27. 5. To transact such other business as may be required.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07 2026.

07-Aug-2026 | Source : BSE

Sub: Outcome of the Meeting of the Board of Directors held on August 07 2026.

1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.

07-Aug-2026 | Source : BSE

Board Meeting Intimation for Intimation Of The Board Meeting.

23-Jul-2026 | Source : BSE

Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby infom you that a meeting of the Board of Directors of Transgene Biotek Limited is scheduled to be held on Friday August 07 2026 inter alia to consider and approve the following matters: 1. To consider and approve the n-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30 2026. 2. To consider and approve the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30h June 2026. 3. To consider and approve seeking an extension of time for holding the Annual General Meeting (AGM) of the Company for the Financial Year 2025-26. 4. To consider and approve the appointment of the internal auditor of the Company for financial year 2026-27. 5. To transact such other business as may be required.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available